How we used a hybrid qual-quant methodology to assess the market opportunity for a new rare disease treatment
Our client is a recently established independent biopharmaceutical company specialising in small molecule development. They were developing a new oral compound for the treatment of a rare genetic disease for which the standard treatment is administered intravenously, however a large proportion of patients receive monitoring only or remain undiagnosed. Their objective was to successfully launch their product in order to provide clinically meaningful benefits to patients and contribute to the overall growth of their business.
How facial analysis was used to evaluate the emotional impact of a disease promotion campaign
Our client had developed a visual and emotion-invoking, online disease awareness campaign aimed at challenging physicians’ current perceptions of treatment. Research was required to understand physicians’ reactions to the campaign (rational and emotional) and whether it would have the desired effect of increasing use of their treatment in the future, to help encourage the client’s local operating companies to adopt and roll out the campaign.
Webcast: Capturing the “moments-of-truth” using online communities and bulletin boards
Download this complimentary webcast in which market research consultants market research consultants Jenny Redfearn and Melinda Shorrdemonstrate how, with careful set-up and management, online communities and bulletin boards can be excellent methods of capturing truer, deeper insights.
Blending qual and quant – the benefits of a hybrid approach
My colleague Chris Gaj and I recently conducted a video dialogue on the topic of hybrid qual/quant methods in which we discussed why clients often want to blend the two, and the best approaches for obtaining qualitative insights with quantitative precision. A typical case would be in-licensing opportunity assessments, which usually require a fast turnaround. The objective of this type of study is to quantify the revenue potential of a possible new asset and ideally provide some depth of insight to support a go/no decision. In other words, answer the key questions: how much? And why?
Taking a hybrid qualitative-quantitative approach to research
US Directors Phil Rosenberg and Chris Gaj discuss ways to achieve qualitative insights with quantitative precision and the benefits of a hybrid approach.